{
    "clinical_study": {
        "@rank": "116055", 
        "acronym": "WRAP-IPF", 
        "arm_group": [
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Subjects to receive standard anti-reflux treatment per clinical discretion"
            }, 
            {
                "arm_group_label": "Surgery", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects will receive laparoscopic fundoplication surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will test the hypothesis that treatment with laparoscopic anti-reflux surgery in\n      subjects with idiopathic pulmonary fibrosis (IPF) and abnormal gastroesophageal reflux (GER)\n      will slow the decline of forced vital capacity (FVC) over 48 weeks."
        }, 
        "brief_title": "Treatment of IPF With Laparoscopic Anti-Reflux Surgery", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Idiopathic Pulmonary Fibrosis", 
            "Gastroesophageal Reflux"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fibrosis", 
                "Gastroesophageal Reflux", 
                "Pulmonary Fibrosis", 
                "Idiopathic Pulmonary Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Confirmed diagnosis of idiopathic pulmonary fibrosis\n\n          -  Abnormal GER on 24-hour impedance/pH monitoring (DeMeester score > 14.7)\n\n          -  Able to provide informed consent\n\n          -  Willing to undergo laparoscopic anti-reflux surgery\n\n        Exclusion Criteria:\n\n          -  FVC < 50% predicted\n\n          -  FEV1/FVC ratio < 0.65\n\n          -  Resting room air PaO2 < 60mm Hg\n\n          -  Unable to walk 50 meters on 6 minute walk test\n\n          -  Acute respiratory illness in last 12 weeks\n\n          -  Experimental medication for IPF in last 28 days\n\n          -  Listed for lung transplantation at screening\n\n          -  Unable to safely undergo surgery\n\n          -  History of esophageal / bariatric / gastric surgery\n\n          -  History of cancer (other than non-melanoma skin cancer) in last 3 years\n\n          -  Pregnant at time of screening or enrollment\n\n          -  Unable to obtain pre-authorized approval from a third party payer for surgery and\n             related costs\n\n          -  Life expectancy < 48 weeks due to another illness\n\n          -  BMI > 35\n\n          -  Known severe pulmonary hypertension (mean pressure > 35 mm Jg on RHC; RVSP > 50 mm Hg\n             on ECHO)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "58", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01982968", 
            "org_study_id": "Pro00049804", 
            "secondary_id": "1UM1HL119089"
        }, 
        "intervention": {
            "arm_group_label": "Surgery", 
            "description": "Full fundoplication surgery for the treatment of abnormal GER", 
            "intervention_name": "Surgery", 
            "intervention_type": "Procedure", 
            "other_name": [
                "Nissen fundoplication", 
                "Laparoscopic fundoplication", 
                "Laparoscopic anti-reflux surgery"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Idiopathic pulmonary fibrosis", 
            "IPF", 
            "Gastroesophageal reflux", 
            "GER", 
            "GERD"
        ], 
        "lastchanged_date": "November 6, 2013", 
        "location": [
            {
                "contact": {
                    "email": "archer.eller@uscf.edu", 
                    "last_name": "Archer Eller"
                }, 
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "University of California"
                }, 
                "investigator": {
                    "last_name": "Harold Collard, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "smalecka@medicine.bsd.uchicago.edu", 
                    "last_name": "Spring Maleckar"
                }, 
                "contact_backup": {
                    "email": "mholly@medicine.bsd.chicago.edu", 
                    "last_name": "Maggie Holly"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "University of Chicago"
                }, 
                "investigator": {
                    "last_name": "Imre Noth, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "ddahlgre@med.umich.edu", 
                    "last_name": "Deb Dahlgren"
                }, 
                "contact_backup": {
                    "email": "clfah@med.umich.edu", 
                    "last_name": "Candace Flaherty"
                }, 
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "University of Michigan"
                }, 
                "investigator": {
                    "last_name": "Kevin Flaherty, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "asnydsma@u.washington.edu", 
                    "last_name": "Angela Snydsman"
                }, 
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington"
                    }, 
                    "name": "University of Washington"
                }, 
                "investigator": {
                    "last_name": "Ganesh Raghu, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "mjwolff@medicine.wisc.edu", 
                    "last_name": "Michele Wolff"
                }, 
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin"
                    }, 
                    "name": "University of Wisconsin"
                }, 
                "investigator": {
                    "last_name": "Keith Meyer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Weighing Risks and Benefits of Laparoscopic Anti-Reflux Surgery in Patients With Idiopathic Pulmonary Fibrosis", 
        "overall_official": [
            {
                "affiliation": "University of California, San Francisco", 
                "last_name": "Hal Collard, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Washington", 
                "last_name": "Ganesh Raghu, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Duke University", 
                "last_name": "Kevin J Anstrom, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Data and Safety Monitoring Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "November 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Decline in FVC (in liters) between enrollment and 48 weeks.", 
            "measure": "Forced vital capacity (FVC)", 
            "safety_issue": "No", 
            "time_frame": "48 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01982968"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Reduction in acid and non-acid reflux events from enrollment to week 48", 
                "measure": "Acid and non-acid reflux events", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Overall safety of laparoscopic anti-reflux surgery in patients with IPF and abnormal GER", 
                "measure": "Safety of laparoscopic anti-reflux surgery", 
                "safety_issue": "Yes", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Impact of anti-reflux surgery on all-cause mortality from enrollment to 48 weeks", 
                "measure": "All-cause mortality", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Impact on non-elective hospitalizations from enrollment to 48 weeks.", 
                "measure": "Non-elective hospitalization", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Impact on acute exacerbations of IPF from enrollment to week 48.", 
                "measure": "Acute exacerbations", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Change in UCSD Shortness of Breath Questionnaire score from enrollment to week 48", 
                "measure": "UCSD SOQB score", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Change in St. George's Respiratory Questionnaire score from enrollment to week 48", 
                "measure": "SGRQ Score", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Change in 6-minute walk distance from enrollment to week 48", 
                "measure": "6-minute walk distance", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Change in cough visual analog scale (VAS) from enrollment to week 48", 
                "measure": "Cough VAS", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }, 
            {
                "description": "Change in HRCT fibrosis score from enrollment to week 48", 
                "measure": "HRCT fibrosis score", 
                "safety_issue": "No", 
                "time_frame": "48 weeks"
            }
        ], 
        "source": "University of California, San Francisco", 
        "sponsors": {
            "collaborator": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}